APA (7th ed.) Citation

L, C., EM, D., KL, W., JR, B., NN, I., TL, B., . . . RA, K. (2025). Exploiting YES1-Driven EGFR Expression Improves the Efficacy of EGFR Inhibitors. Molecular cancer research : MCR, 23(5), 391-404. https://doi.org/10.1158/1541-7786.MCR-24-0309

Chicago Style (17th ed.) Citation

L, Cuellar-Vite, Donaubauer EM, Weber-Bonk KL, Bobbitt JR, Ingles NN, Brzozowski TL, Abdul-Karim FW, Booth CN, and Keri RA. "Exploiting YES1-Driven EGFR Expression Improves the Efficacy of EGFR Inhibitors." Molecular Cancer Research : MCR 23, no. 5 (2025): 391-404. https://doi.org/10.1158/1541-7786.MCR-24-0309.

MLA (9th ed.) Citation

L, Cuellar-Vite, et al. "Exploiting YES1-Driven EGFR Expression Improves the Efficacy of EGFR Inhibitors." Molecular Cancer Research : MCR, vol. 23, no. 5, 2025, pp. 391-404, https://doi.org/10.1158/1541-7786.MCR-24-0309.